Work

A Phase 2, Randomized, Multicenter Study of 1 or 3 Doses of ZYC101A in the Treatment of High-grade Squamous Intraepithelial Lesions of the Uterine Cervix

FWCI:
Cites:
Cited by:
Related to: 10